Position in OCUL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$49,307,123
+$10,944,927 QoQ
Shares Held
5,021,092
+10.9% QoQ
Ownership
2.29%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 257 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,870,628,057 across 520 Biotechnology names. OCUL ranks #84 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in OCUL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,307,123 | 5,021,092 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $38,362,196 | 4,529,185 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $52,888,480 | 4,356,547 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $39,026,515 | 3,338,453 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $30,477,106 | 3,284,171 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $25,086,279 | 3,422,412 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $27,638,103 | 3,236,312 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $28,459,500 | 3,271,207 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $23,612,274 | 3,452,087 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $22,622,991 | 2,486,043 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $7,746,190 | 1,736,814 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,116,717 | 1,629,528 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $8,100,704 | 1,569,904 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,682,289 | 1,457,740 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,963,934 | 1,410,653 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $5,688,624 | 1,370,753 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,432,728 | 1,351,425 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,751,651 | 1,363,970 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $9,181,852 | 1,317,339 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $13,122,350 | 1,312,235 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $18,502,049 | 1,304,799 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $20,177,867 | 1,229,608 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $22,570,265 | 1,090,351 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,741,744 | 885,906 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $6,774,439 | 813,258 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,250,422 | 656,651 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||